Table 1 Demographic, clinical and biological data of the patients and healthy controls at baseline
Variables | Healthy controls ( n = 15) (mean ± SD) | Responders ( n = 37) (mean ± SD) | Non-responders ( n = 15) (mean ± SD) | P value |
|---|---|---|---|---|
Age (years) | 46.33 ± 2.94 | 52.44 ± 10.90 | 52.08 ± 10.87 | .918 |
Sex (men/women) | 33.33%/66.67% | 27.78%/72.22% | 38.46%/61.54% | .351 |
CRP (mg/dl) | 12.68 ± 7.97 | 15.59 ± 6.86 | .251 | |
Rheumatoid factor (+/−) | 91.67%/8.33% | 92.31%/7.69 | .716 | |
Anti-CCP (UI/ml)/(+/−) | 445.96 ± 463.46 (89.19%/10.81%) | 418.83 ± 229.47 (86.66%/13.34%) | .848 | |
DAS28 | 3.38 ± .54 | 3.55 ± .76 | .399 | |
Erosions (+/−) | 33.33%/66.67% | 38.46%/61.54% | .496 | |
Onset of symptoms (months) | 12.83 ± 8.95 | 11.86 ± 9.49 | .819 | |
HAQ | .79 ± .52 | .78 ± .49 | .935 |